HHS selects 10 drugs for gov’t price setting under Medicare; industry says patients will suffer

The Biden administration on Tuesday selected 10 drugs that will be part of a historic first round of price negotiation through Medicare, including the blood thinner Xarelto and Type-2 diabetes drugs Jardiance and Januvia.